Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype
- PMID: 33637072
- PMCID: PMC7913423
- DOI: 10.1186/s12931-021-01635-w
Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype
Abstract
Background: Chlamydia pneumoniae and Mycoplasma pneumoniae have been implicated in the pathogenesis of asthma and are responsible for chronic inflammation when host immune system fails to eradicate the bacteria.
Method: We performed a prospective study on 410 patients who underwent a visit at the asthma clinic of CHU of Liege between June 2016 and June 2018 with serology testing for C. pneumoniae and M. pneumoniae.
Results: 65% of our asthmatic population had serum IgA and/or IgG towards C. pneumoniae, while only 12.6% had IgM and/or IgG against M. pneumoniae. Compared to seronegative asthmatics, asthmatics with IgA+ and IgG+ against C. pneumoniae were more often male and older with a higher proportion of patients with smoking history. They received higher doses of inhaled corticosteroids (ICS) and displayed lower FEV1/FVC ratio, higher RV/TLC ratio and lower conductance. They had higher levels of fibrinogen, though in the normal range and had lower sputum eosinophil counts. Patients with IgA- and IgG+ against C. pneumoniae were older and had higher blood monocyte counts and alpha-1-antitrypsin levels as compared to seronegative patients. Patients with IgM and/or IgG towards M. pneumoniae were more often males than seronegative asthmatics. In a subpopulation of 14 neutrophilic asthmatics with Chlamydia pneumoniae IgA + /IgG + treated with macrolides, we found a significant decrease in blood neutrophils and normalization of sputum neutrophil count but no effect on asthma quality of life and exacerbations.
Conclusion: Positive Chlamydia serologic test is more common than positive Mycoplasma serology. Asthmatics with IgA and IgG against C. pneumoniae have more severe disease with increased airway obstruction, higher doses of ICS, more signs of air trapping and less type-2 inflammation.
Keywords: Asthma; Chlamydia pneumoniae; Macrolides; Neutrophils; Phenotypes; Sputum.
Conflict of interest statement
The authors declare that they have no competing interests related to this manuscript. Renaud Louis received grants from GSK, Astrazeneca, Novartis and Chiesi and personal fees from GSK, Astrazeneca and Novartis. Florence Schleich received grants from GSK and Astrazeneca and personal fees from GSK and Chiesi. Other co-authors have nothing to declare.
Figures


Similar articles
-
Prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae IgM and IgG antibodies in Tunisian patients presenting with exacerbation of chronic obstructive pulmonary disease.Med Mal Infect. 2017 Mar;47(2):158-163. doi: 10.1016/j.medmal.2016.12.002. Epub 2017 Jan 3. Med Mal Infect. 2017. PMID: 28062246
-
Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control.Allergy Asthma Proc. 2011 Mar-Apr;32(2):9-17. doi: 10.2500/aap.2011.32.3431. Allergy Asthma Proc. 2011. PMID: 21439159
-
Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae and Helicobacter pylori.J Trop Pediatr. 2007 Oct;53(5):313-8. doi: 10.1093/tropej/fmm040. Epub 2007 May 29. J Trop Pediatr. 2007. PMID: 17535826
-
[Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections].Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):409-19. Ann Biol Clin (Paris). 2006. PMID: 17040871 Review. French.
-
[Role of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in the course of asthma].Pneumonol Alergol Pol. 2010;78(4):284-95. Pneumonol Alergol Pol. 2010. PMID: 20665449 Review. Polish.
Cited by
-
Progress in diagnosis and treatment of difficult-to-treat asthma in children.Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231213637. doi: 10.1177/17534666231213637. Ther Adv Respir Dis. 2023. PMID: 38069568 Free PMC article. Review.
-
Immunosenescence, Inflammaging, and Lung Senescence in Asthma in the Elderly.Biomolecules. 2022 Oct 11;12(10):1456. doi: 10.3390/biom12101456. Biomolecules. 2022. PMID: 36291665 Free PMC article. Review.
-
Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP.BMC Infect Dis. 2025 Aug 7;25(1):993. doi: 10.1186/s12879-025-11405-4. BMC Infect Dis. 2025. PMID: 40775274 Free PMC article.
-
Type 2 or Non-Type 2 Asthma Exacerbations? That Is the Question.Am J Respir Crit Care Med. 2022 Sep 1;206(5):521-522. doi: 10.1164/rccm.202205-0857ED. Am J Respir Crit Care Med. 2022. PMID: 35584351 Free PMC article. No abstract available.
-
Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.Eur Respir J. 2024 Aug 15;64(2):2300826. doi: 10.1183/13993003.00826-2023. Print 2024 Aug. Eur Respir J. 2024. PMID: 38697650 Free PMC article. Review.
References
-
- Hahn DL. Infectious asthma: a reemerging clinical entity? J Fam Pract. 1995;41(2):153–157. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous